risankizumab,tofacitinib,vedolizumab,azacitidine,ustekinumab,ozanimod,upadacitinib,adalimumab,golimumab,infliximab
abbvie,bms,janssen,takeda,pfizer
[' vedo', 'ibd']
 with a great review of of how he personalizes ibd therapy, need to consider patient specific factors (disease phenotype, eims, safety). and remember surgery may be the best therapy! #aibd2022 
Gastroenterologist & IBD specialist @NYULangone with focus on EIMs @MonteGastro @SUNYdownstate @Cornell alum ???????? Husband/father of 2